The Human L-type Calcium Channel Cav1.3 Regulates Insulin Release and Polymorphisms in CACNA1D Associate with Type 2 Diabetes
Overview
Affiliations
Aims/hypothesis: Voltage-gated calcium channels of the L-type have been shown to be essential for rodent pancreatic beta cell function, but data about their presence and regulation in humans are incomplete. We therefore sought to elucidate which L-type channel isoform is functionally important and its association with inherited diabetes-related phenotypes.
Methods: Beta cells of human islets from cadaver donors were enriched using FACS to study the expression of the genes encoding voltage-gated calcium channel (Cav)1.2 and Cav1.3 by absolute quantitative PCR in whole human and rat islets, as well as in clonal cells. Single-cell exocytosis was monitored as increases in cell capacitance after treatment with small interfering (si)RNA against CACNA1D (which encodes Cav1.3). Three single nucleotide polymorphisms (SNPs) were genotyped in 8,987 non-diabetic and 2,830 type 2 diabetic individuals from Finland and Sweden and analysed for associations with type 2 diabetes and insulin phenotypes.
Results: In FACS-enriched human beta cells, CACNA1D mRNA expression exceeded that of CACNA1C (which encodes Cav1.2) by approximately 60-fold and was decreased in islets from type 2 diabetes patients. The latter coincided with diminished secretion of insulin in vitro. CACNA1D siRNA reduced glucose-stimulated insulin release in INS-1 832/13 cells and exocytosis in human beta cells. Phenotype/genotype associations of three SNPs in the CACNA1D gene revealed an association between the C allele of the SNP rs312480 and reduced mRNA expression, as well as decreased insulin secretion in vivo, whereas both rs312486/G and rs9841978/G were associated with type 2 diabetes.
Conclusion/interpretation: We conclude that the L-type calcium channel Cav1.3 is important in human glucose-induced insulin secretion, and common variants in CACNA1D might contribute to type 2 diabetes.
Jan A, Alanzi A, Mothana R, Kaimori J, Ali S, Muhammad T Pharmgenomics Pers Med. 2024; 17:473-486.
PMID: 39492848 PMC: 11531276. DOI: 10.2147/PGPM.S481068.
The L-type calcium channel CaV1.3: A potential target for cancer therapy.
Liu X, Shen B, Zhou J, Hao J, Wang J J Cell Mol Med. 2024; 28(19):e70123.
PMID: 39365143 PMC: 11451265. DOI: 10.1111/jcmm.70123.
He M, Niu J, Cheng H, Guo C Front Genet. 2024; 15:1373807.
PMID: 39296548 PMC: 11408200. DOI: 10.3389/fgene.2024.1373807.
Association Study of , , , and Single-Nucleotide Polymorphisms with Type 2 Diabetes Mellitus.
Diaz-Garcia J, Leyva-Leyva M, Sanchez-Aguillon F, de Leon-Bautista M, Fuentes-Venegas A, Torres-Viloria A Int J Mol Sci. 2024; 25(17).
PMID: 39273144 PMC: 11395491. DOI: 10.3390/ijms25179196.
Visa M, Berggren P Diabetologia. 2024; 67(8):1663-1682.
PMID: 38814444 PMC: 11343800. DOI: 10.1007/s00125-024-06173-w.